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Abstract
Background
We undertook a systematic review and meta-analysis to address the question “what is the
impact of meningitis on IQ and development.”
Methods
Search: conducted using standardized search terms across Medline, PsychInfo and
EMBASE to 06/2014. Eligibility: human studies of any infectious aetiology of meningitis
reporting IQ or infant developmental age or stage outcomes. Quality: Centre for Evidence
Based Medicine, Oxford, quality tools. Analysis: random effects meta-analysis by organism.
Results
39 studies were included in the review, 34 providing data on IQ (2015 subjects) and 12 on
developmental delay (382 subjects). Across all bacterial organisms, meningitis survivors
had a mean IQ 5.50 (95% CI: -7.19, -3.80; I2 = 47%, p = 0.02) points lower than controls. IQ
was significantly lower than controls for Neisseria meningitides (NM: 5 points) and Haemo-
philus influenzae b (Hib: 6 points) but not in viral meningitis, with only single studies included
for Streptococcus pneumoniae (SP) and group B streptococcus (GBS). The pooled relative
risk (RR) for low IQ (IQ<70) in survivors of bacterial meningitis compared with controls was
4.99 (95% CI: 3.17, 7.86) with no significant heterogeneity (I2 = 49%, p = 0.07). Develop-
mental delay of approximately 0.5SD was reported in studies of bacterial meningitis but no
delay in the only study of viral meningitis.
Conclusions
We found moderate evidence that surviving bacterial meningitis has a deleterious impact on
IQ and development but no evidence that viral meningitis had meaningful cognitive impacts.
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Survivors of bacterial meningitis should be routinely offered screening for cognitive deficits
and developmental delay in addition to hearing loss.
Background
The epidemiology of bacterial meningitis has changed substantially over the past century. The
use of conjugate vaccines over the last couple of decades has drastically changed the epidemiol-
ogy of the disease in high income countries, leading to ‘near elimination’ of Haemophilus influ-
enzae b [Hib] meningitis as well as serogroup type C meningococcal meningitis.[1] However,
worldwide bacterial meningitis remains a major cause of morbidity and mortality, causing
annually over 303,000 deaths and 2,628,000 years lived with disability.[2, 3] In Asia and Africa
about one fifth to a quarter of survivors suffer from long-term sequelae.[4]
In the era of conjugate vaccines, viral rather than bacterial meningitis is the most common
form of meningitis in high income countries. Amongst bacterial causes, the previously less
common group B streptococcus (GBS) is now the most common pathogen causing purulent
meningitis.[5] Improvements in management and antibiotics now limit mortality and serious
sequelae in those bacterial cases that do occur,[6] whilst sequelae of aseptic meningitis are usu-
ally limited to subtle neurocognitive problems.[7]
Systematic reviews of the outcomes of meningitis are limited to bacterial meningitis and
have not assessed in detail on the impact of meningitis on key neurocognitive outcomes such
as intelligence and development. Intelligence Quotient (IQ) is a construct used within stan-
dardized tests as a measure of an individual’s intelligence level. Current IQ tests measure two
primary components; verbal IQ (VIQ) relates to verbal and language abilities, reasoning and
arithmetic skills and verbal memory. Performance IQ (PIQ) in contrast relates to visuospatial
and performance skills. In young children or in those who cannot complete formal IQ tests,
concepts of developmental delay (DD) are frequently used. DD is defined as delay in meeting
developmental milestones in one or more domains of development. Key domains are similar
to those used in measuring IQ, and include cognition, language, visual problem solving, motor
development and social-emotional development. There is not surprisingly a major overlap
between the two constructs.
A systematic review of sequelae due to bacterial meningitis in African children did not
report on IQ.[8] The most recent and comprehensive systematic review of disabling sequelae
from bacterial meningitis reported only on the prevalence of major cognitive deficits, defined
as IQ<70.[4]
Overall intelligence, measured by IQ, is one of the strongest predictors of an individual’s
future life chances, material and subjective well-being and health.[9, 10] Even small deficits in
IQ following meningitis can impair life-chances and educational attainments.[11] IQ can be
difficult to assess in very young children, a majority of those studied in meningitis outcome
studies, and studies may instead estimate DD.
We undertook a systematic review and meta-analysisof the neurocognitive outcomes of
meningitis of all causes in humans published in the last 50 years to address the question “what
is the impact of meningitis on IQ and development”.
Methods
Data for this review were obtained from a wider review of the complications and sequelae of
meningitis.
Meningitis and IQ: A meta-analysis
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Search
The search terms used aimed to be as inclusive as possible to identified any complications
or sequelae of meningitis. We undertook a computerised search of the MEDLINE (6/1964–
06/2014) database using the MeSH terms: [“Meningitis” AND (“Meningitis/complications”
OR “Meningitis/psychology” OR “Meningitis/rehabilitation”)]. We also searched Psy-
choINFO (1955-06/2014) and EMBASE (1982-06/2014) using similar terms. Eligible studies
were observational studies of long term outcomes subsequent to meningitis meeting the fol-
lowing inclusion and exclusion criteria. The reference lists of identified articles were then
hand searched for further relevant studies. We also hand-searched identified systematic
reviews.[4, 8, 12]
Eligibility
For the wider review, eligibility criteria were human studies of any age-group; laboratory
proven meningitis of any infectious aetiology together with meningococcal septicaemia; stud-
ies must address outcomes/sequelae or complications of meningitis other than death or acute
complications; time-scale: Outcomes or follow-up reported1 month after meningitis; study
type: prospective and retrospective cohort, case–control, or cross-sectional studies of outcomes
following meningitis; and language of publication was English or a published English transla-
tion was available. We excluded studies involving only acute complications (<1 month after
onset); single or multiple case reports; papers published before 1955; papers published in lan-
guages other than English (except if published English translation) and meningitis in immuno-
suppressed populations.
Study selection
Articles identified by the electronic searches were examined by 1 of 2 reviewers. Articles that
clearly did not meet eligibility criteria were rejected on initial review. Articles marked for
potential inclusion were than obtained electronically or in paper copy, and assessed again for
inclusion. Those included studies deemed to potentially meet inclusion criteria were
appraised. A form was used to record all details of the papers reviewed. Where repeated assess-
ments of a cohort had been reported at different times, only the latest and most comprehensive
assessment was included in the review.
Eligibility for this review
For this paper we applied further eligibility criteria. Eligible studies were those that assessed IQ
or infant developmental age or stage using validated instruments and reported any of the fol-
lowing outcomes:
a. Intelligence: mean full-scale, performance IQ (PIQ) or verbal IQ (VIQ) reported as stan-
dardized scores (mean 100, SD 15) or proportions with low IQ (<70 i.e.>2 standard devia-
tions (SDs) below mean)
b. Infant development: outcomes of interest were developmental performance in motor,
language or cognitive domains compared with normative data, providing a measure of DD.
We did not include studies which reported IQ or developmental outcomes on subsets of
meningitis survivors e.g. those with or without neurological sequelae. We did not include stud-
ies which reported only certain IQ subscales. For case-control studies, we only included studies
which reported details of control recruitment and matching.
Meningitis and IQ: A meta-analysis
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Quality
Each publication was reviewed and graded by using Evidence Based Medicine tools devised by
the Centre for Evidence Based Medicine, Oxford (http://www.cebm.net). Studies were classi-
fied as retrospective or prospective cohort studies (depending on whether meningitis preceded
or anteceded cohort recruitment) or case-control studies (if a retrospectively defined sample
of meningitis subjects were compared with a healthy control group).
Data extraction
Data were extracted by one reviewer and then checked by a clinical neuropsychologist (DC) to
ensure accuracy.
Analysis
Descriptive analyses were first undertaken of the distribution of each outcome by causative
organism. Where data allowed, random effects meta-analyses were undertaken in Stata13
(StataCorp; College Station, TX) using the metan commands. The level of significance used
was the 0.05 level. Study weights were assigned automatically by Stata. Where IQ SDs were
not reported, these were obtained from standard errors, confidence intervals, t values or p
values that relate to the differences between means in two groups. Where SD values for IQ
were not available through the above methods, an SD of 15 was substituted as IQ scales are
normed to have a mean of 100 with an SD of 15. Where there were serial published follow-
up studies on the same cohort, we only included the latest assessment study. Where papers
presented case-control findings both unmatched and matched, the matched analyses were
used in this review.
We first conducted meta-analyses across all bacterial causes. Separate metanalyses were
conducted by organism only where3 studies were available in each category. The DerSimo-
nian and Laird Q test was performed to assess the degree of heterogeneity between studies,
and the I2 statistic was used to describe the percentage of total variation across studies due to
heterogeneity.
Reporting
The QUORUM (Quality of Reporting of Meta-analyses) guideline was used for reporting our
review.[13]
Results
Searches yielded 3527 articles, of which 299 papers were selected for full-text reviewing and
196 were included in the wider review of all meningitis complications and sequelae. Of these,
48 papers included estimates of IQ and / or developmental delay meeting our additional eligi-
bility criteria, of which 9 were duplicate publications on the same cohorts, thus 39 papers were
included in these analyses. 34 studies provided data on IQ including 2015 survivors, and 12
studies on the prevalence of DD were included representing 382 survivors (see Fig 1 for search
flow chart). Characteristics of the included papers are shown in S1 Table. Only 7 studies came
from low- or middle-income countries.
The vast majority of studies were of those with meningitis in early childhood, who were
then followed up later in childhood and adolescence. There was only one study each of adoles-
cent onset meningitis (Borg et al. 2009) and of meningitis in adults (Merkelbach et al. 2000).
Meningitis and IQ: A meta-analysis
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IQ data
Of the 34 IQ studies, 9 studies (26%) were retrospective cohort studies, 1 (3%) was a prospec-
tive cohort study and 24 (71%) were case-control studies. 8 (24%) studies recruited cases from
population-based samples, with the remaining 26 (76%) being clinical series recruited from
one or more hospitals. Of the case-control studies, most matched controls for age and sex,
with the majority matching controls on the basis of socioeconomic status, either by using sib-
ling controls or by matching population controls.
Fig 1. Study selection flowchart for review.
https://doi.org/10.1371/journal.pone.0175024.g001
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In terms of organism, 8 (24%) studies included any bacterial cause with an additional 3
(9%) studies of neonatal bacterial meningitis. 8 (24%) studies were of Haemophilus influenzae
b (Hib), 3 (9%) of Streptococcus pneumoniae (SP) and 1 (3%) of Hib and SP, 4 (12%) studies
were of Neisseria meningitides (NM), 2 (6%) of group B streptococcus (GBS), 2 (6%) of tuber-
culosis (TB) and 3 (9%) studies were of viral meningitis.
Mean full-scale IQ in meningitis survivors was reported in 23 (68%) studies, with 19 (56%)
reporting the prevalence of low IQ defined as IQ<70 and 9 (26%) reporting mean VIQ or
PIQ.
Study quality: 2 studies were graded as providing level 2a evidence, 20 studies as level 3b
and 12 studies as level 4.
Mean IQ. Table 1 shows the characteristics of studies reporting mean IQ and proportions
with low IQ by organism. The overall mean full-scale IQ in the whole group across all organ-
isms was 97.1 (n = 26; SD 7.2; range 79 to 110). The mean and median of all organism groups
were within 1 standard deviation of the normal IQ range, although no studies reported mean
IQ in TB meningitis.
Meta-analysis of mean IQ in survivors across studies was undertaken where more than 3
studies per category were available (Fig 2). Mean IQ estimates appeared highest for viral men-
ingitis and lowest for Hib, but were not significantly different to 100 in any organism. There
were insufficient data to repeat meta-analyses including only population-based studies for any
organism. There was substantial heterogeneity (I2>90%) in all meta-analyses except that for
viral meningitis.
Comparison of IQ in survivors compared with controls was reported by 21 studies. Fig 3
shows a Forest plot of a random effects meta-analysis of differences in IQ between survivors
and controls. Note that one Hib study (D’Angio et al. 1995) was excluded as this was a study of
Navajo Native Indian children in whom there are recognized issues with poor performance on
IQ tests related to cultural issues.[14] The single studies found for GBS and SP meningitis are
also shown in Fig 3 to demonstrate the data. Survivors of bacterial all-cause, NM and Hib men-
ingitis had a significantly lower IQ than controls, of the order of 5 IQ points for NM and for
Hib and 6 for bacterial all-cause meningitis. There was substantial and significant heterogene-
ity in the bacterial all-cause, and NM but not the Hib analyses. In the single SP study, Christie
et al. 2009 reported a significant deficit of 5 IQ points in survivors compared with matched
Table 1. Full scale IQ: Mean IQ and proportions with low IQ (70) by organism.
Full-scale IQ IQ <70
N of studies Mean (SD) Range N of studies Mean % (SD) Range
Bacterial all-cause 6 97.2 (7.3) (88.8, 110) 4 9.3 (3.4) (6, 13.5)
Neonatal bacterial all-cause 1 90 (-) - 3 27.3 (10.9) (16.7, 38.5)
Neisseria meningitides (NM) 4 97.2 (4.5) (92.9, 102.1) 1 0.8 (-) -
Haemophilus influenzae b (Hib) 7 94.6 (9.9) (79, 108) 5 11.5 (10.5) (1, 24.4)
Streptococcus pneumoniae (SP) 1 102.4 (-) - 2 25.6 (22) (10, 41.2)
Group B streptococcus (GBS) 1 101.9 (-) 1 15.0 (-) -
TB 0 - - 2 26.3 (24.2) (9.2, 43.4)
Viral 3 101.6 (3.2) (97.9, 104) 1 3.03 (-) -
Notes
For single studies, the mean indicates the published value. SD and range only calculated where there are >1 study.
No studies of all cause meningitis provided quantitative data in either category.
For single studies, the mean indicates the published value. SD and range only calculated where there are >1 study
https://doi.org/10.1371/journal.pone.0175024.t001
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controls, whilst the only GBS study (Wald et al. 1986) was underpowered to detect a difference.
A separate meta-analysis across all studies of bacterial organisms (not shown) found that men-
ingitis survivors had a mean IQ 5.50 (95% CI: -7.19, -3.80; I2 = 47%, p = 0.02) points lower
than controls.
The pooled estimate for viral meningitis was not significantly different to 0, with non-sig-
nificant heterogeneity.
Only 2 studies, Christie et al (2009) and Viner et al. (2012), reported IQ estimates in menin-
gitis survivors and healthy controls without moderate/severe hearing loss. Both studies
NOTE: Weights are from random effects analysis
.
.
.
.
Bacterial
Anderson 2004
Dodge et al. 2001
Merkelbach et al.2000
Salih et al. 1991
Stevens et al.2003
Subtotal  (I−squared = 94.8%, p = 0.000)
HIB
D’Angio et al.1995
Emmett et al. 1980
Sell et al. 1972
Taylor et al. 1984
Taylor et al. 1990
Tejani et al. 1982
Wright et al. 1971
Subtotal  (I−squared = 94.2%, p = 0.000)
NM
Borg et al. 2009
Fellick et al. 2001
Moss 1982
Viner et al. 2012
Subtotal  (I−squared = 90.2%, p = 0.000)
Viral
Baker et al. 1996
Bergman et al. 1987
Chamberlain et al. 1983
Subtotal  (I−squared = 3.0%, p = 0.357)
ID
Study
97.20 (95.04, 99.36)
105.00 (100.62, 109.38)
110.00 (104.90, 115.10)
92.30 (86.05, 98.55)
88.80 (86.18, 91.42)
98.57 (91.62, 105.53)
79.00 (73.49, 84.51)
103.20 (99.22, 107.18)
86.00 (79.58, 92.42)
96.70 (90.70, 102.70)
108.00 (104.80, 111.20)
97.00 (87.98, 106.02)
92.60 (83.30, 101.90)
94.78 (86.27, 103.30)
102.10 (99.84, 104.36)
92.90 (89.92, 95.88)
94.00 (90.20, 97.80)
99.80 (98.10, 101.50)
97.40 (93.36, 101.43)
104.00 (97.76, 110.24)
102.81 (95.46, 110.16)
97.90 (91.77, 104.03)
101.40 (97.59, 105.22)
ES (95% CI)
21.21
19.94
19.40
18.43
21.01
100.00
14.61
15.05
14.30
14.44
15.23
13.25
13.13
100.00
25.96
24.50
22.62
26.92
100.00
36.23
26.32
37.45
100.00
Weight
%
  
85 100 115
Fig 2. Forest plot of meta-analysis of mean IQ estimates by organism. Abbreviations: Haemophilus influenzae b (Hib), Streptococcus pneumoniae
(SP) Neisseria meningitides (NM), group B streptococcus (GBS)
https://doi.org/10.1371/journal.pone.0175024.g002
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reported that exclusion of those with hearing loss did not affect mean IQ estimates or differ-
ences with matched controls.
Low IQ. Data on proportions of meningitis survivors with low IQ (<70 points) are shown
in Table 1. Mean prevalence of low IQ (<70) across all organisms was 17.2% (SD 14.6), range
NOTE: Weights are from random effects analysis
.
.
.
.
.
.
Bacterial
Anderson et al. 2004
Dodge et al. 2001
Merkelbach et al.2000
Salih et al. 1991
Stevens et al.2003
Subtotal  (I−squared = 67.4%, p = 0.016)
GBS
Wald et al. 1986
Subtotal  (I−squared = .%, p = .)
HIB
Emmett et al. 1980
Sell et al. 1972
Taylor et al. 1984
Taylor et al. 1990
Tejani et al. 1982
Wright et al. 1971
Subtotal  (I−squared = 0.0%, p = 0.457)
NM
Borg et al. 2009
Fellick et al. 2001
Moss 1982
Viner et al. 2012
Subtotal  (I−squared = 74.3%, p = 0.009)
SP
Christie et al. 2009
Subtotal  (I−squared = .%, p = .)
Viral
Baker et al. 1996
Bergman et al. 1987
Chamberlain et al. 1983
Subtotal  (I−squared = 49.0%, p = 0.141)
ID
Study
−4.40 (−7.60, −1.20)
1.00 (−5.66, 7.66)
−7.00 (−14.34, 0.34)
−8.40 (−16.15, −0.65)
−10.60 (−14.03, −7.17)
−6.08 (−10.09, −2.08)
−2.16 (−14.50, 10.18)
−2.16 (−14.50, 10.18)
−3.20 (−9.41, 3.01)
−11.00 (−20.07, −1.93)
−7.30 (−15.04, 0.44)
−2.40 (−6.94, 2.14)
−4.60 (−17.35, 8.15)
−12.00 (−25.15, 1.15)
−4.80 (−7.74, −1.85)
−2.20 (−5.21, 0.81)
−8.20 (−12.35, −4.05)
−1.10 (−6.47, 4.27)
−7.40 (−9.61, −5.19)
−4.97 (−8.37, −1.58)
−5.60 (−9.43, −1.77)
−5.60 (−9.43, −1.77)
−10.00 (−17.60, −2.40)
−5.10 (−13.77, 3.57)
−4.73 (−11.85, 2.39)
WMD (95% CI)
26.75
17.06
15.49
14.61
26.08
100.00
100.00
100.00
22.50
10.54
14.50
42.09
5.34
5.02
100.00
27.56
23.07
18.73
30.64
100.00
100.00
100.00
38.33
27.78
33.89
100.00
Weight
%
3.00 (−7.39, 13.39)
  
0−10 −5 5 10
Fig 3. Forest plot of meta-analysis of weighted mean difference in IQ between meningitis survivors and controls by organism. Abbreviations:
Haemophilus influenzae b (Hib), Streptococcus pneumoniae (SP) Neisseria meningitides (NM), group B streptococcus (GBS)
https://doi.org/10.1371/journal.pone.0175024.g003
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0.8 to 44.4%. The highest prevalence of low IQ was seen in neonatal, SP and TB meningitis;
however exclusion of 1 study (Doctor et al, 2001) which included only low-birth weight neo-
nates resulted in an estimate of 14.4% for neonatal meningitis. It was not possible to perform a
meta-analysis of the prevalence of low IQ across studies due to insufficient data.
Case-control data for low IQ were reported by 11 studies: 2 bacterial all-cause studies, 4
Hib, 1 NM, 2 neonatal, 1 SP and 1 viral study (see Fig 4). In meta-analysis, the pooled relative
risk (RR) for low IQ in survivors of bacterial meningitis (any organism, excluding D’Angio
et al. 1995) compared with controls was 4.99 (95% CI: 3.17, 7.86). Meta-analysis by organism
was only possible for Hib studies: pooled relative risk for low IQ (excluding D’Angio et al.
1995) was not significantly different to zero: RR = 3.67 (95% CI: 0.63, 21.17).
Verbal IQ and performance IQ. Data on VIQ and PIQ were reported by 11 studies: 1
bacterial all-cause, 2 NM, 4 Hib, 1 SP, 1 GBS and 2 viral. Note that one study, Dodge et al.
2001, reported findings from younger and older children using different IQ tests which cannot
be combined in meta-analysis: here we only include the larger sample of younger children. A
further 4 included studies either provided insufficient data on VIQ or PIQ to review or used
non-standardised measures. Fig 5 shows a Forest plot of mean difference in VIQ and PIQ
between meningitis survivors and controls by organism. Across all bacterial causes, pooled
mean difference between survivors and controls for VIQ was -3.73 (95%CI: -6.38, -1.09; I2 =
54%, p = 0.03) and for PIQ -4.38 (95% CI: -7.03, -1.73; I2 = 48%, p = 0.05). Meta-analysis by
organism was only possible for Hib: pooled weighted mean difference for IQ was -3.20 (95%
CI: -6.25, -0.15)) and PIQ (-5.41 (-10.12, -0.70).
Developmental delay. Twelve included studies reported developmental performance
subsequent to meningitis; 3 studies reported on bacterial all-cause meningitis, 2 of neonatal
meningitis, 4 for Hib, 1 for NM, 3 for SP, 1 for GBS and 3 viral (note some studies provided
data for more than 1 organism). Six were case-control studies with the remainder being ret-
rospective cohort studies. DD was reported using varying definitions of delay and using
multiple different instruments. Seven DD studies were graded as providing level 3b evi-
dence and 5 as level 4.
Table 2 summarises findings from the 12 studies by organism, showing differences in effect
sizes between survivors and controls reported from case-control studies (as Cohen’s d) and the
prevalence of DD in survivors from cohort studies. DD of approximately 0.5SD compared
with controls was reported in the majority of case-control studies of bacterial causes, with the
exception being the single Hib study (Wright et al. 1971) which reported no delay in cognitive
development. Note that the sole neonatal bacterial study (Doctor et al. 2001) included only
newborns with low birth weight (<1.5kg). Developmental domains assessed in bacterial stud-
ies varied across studies and it was not possible to summarize data by domain. No delay com-
pared with controls was reported in either viral case-control study. Reported prevalence of DD
in the retrospective cohort studies varied greatly from 0 to 35% across studies of bacterial
causes. The only study of viral meningitis reported no identified DD across motor, language or
cognitive development.
Discussion
We found moderate evidence that surviving bacterial meningitis has a deleterious impact on
IQ and development but no evidence that viral meningitis had an impact on IQ. Survivors of
bacterial meningitis had an approximately 5 point reduction in IQ compared with healthy con-
trols, a deficit that was similar across all organisms and equivalent to a 0.33 SD reduction in
IQ. Survivors of bacterial meningitis were 5-fold more likely to have intellectual impairment
(IQ<70) than controls. Studies of DD in younger survivors suggested an 0.5SD deficit that was
Meningitis and IQ: A meta-analysis
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largely consistent across bacterial causes, and was reported across multiple domains including
cognitive, social, language and motor development.
Our findings suggest that bacterial but not viral meningitis results in a leftward shift of the
IQ distribution, lowering mean IQ and increasing the proportion with moderately severe intel-
lectual impairment and DD. The impact of meningitis appeared to be of a similar order on
VIQ and PIQ, suggesting a broad non focal impact upon cognitive function similar to the
Bacterial
Stevens et al.2003
Salih et al. 1991
HIB
D’Angio et al.1995
Sell et al. 1972
Taylor et al. 1990
Tejani et al. 1982
Neonatal Bacterial all cause
Doctor et al. 2001
Franco et al. 1992
NM
Viner et al. 2012
SP
Saha et al. 2009
Viral
Bergman et al. 1987
ID
Study
15.27 (2.05, 113.65)
(Excluded)
10.00 (1.34, 74.60)
4.00 (0.49, 32.87)
3.00 (0.12, 72.73)
(Excluded)
2.75 (1.82, 4.15)
8.44 (0.50, 143.77)
2.67 (0.24, 29.24)
21.00 (2.93, 150.31)
1.00 (0.07, 14.64)
RR (95% CI)
  1.00665 150
Fig 4. Forest plot of relative risk of low IQ (IQ<70) in meningitis survivors compared with controls by organism. Abbreviations: Haemophilus
influenzae b (Hib), Streptococcus pneumoniae (SP) Neisseria meningitides (NM), group B streptococcus (GBS)
https://doi.org/10.1371/journal.pone.0175024.g004
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effects of non-specific brain injury. This is also supported by the broad range of domains
reported to have developmental delays in differing studies. Whilst it is notable that mean IQ in
survivors remained in the normal range across all organisms, an 0.33SD reduction is likely to
be highly meaningful for those with premorbid IQ in the lower part of the IQ distribution.
Those with low IQ or moderately severe intellectual impairment are likely to have much
poorer educational attainments, poorer later employment opportunities and a range of poorer
health outcomes.
We found no high quality studies of the cognitive outcomes of TB, fungal or parasitic men-
ingitis. We found little evidence that neonatal meningitis had a greater impact than meningitis
later in early childhood, with estimates for the relative risk of low IQ similar to those for men-
ingitis in later childhood. Given that only two studies specifically examined periods after early
childhood, we could not examine whether meningitis in childhood had a greater or lesser
impact on outcomes. Data limitations meant that we were not able to examine the impact
severity of meningitis on outcomes.
Comparison with literature
No previous studies have systematically reviewed the impact of meningitis on mean full-scale
IQ or its verbal and performance components. Our finding that the pooled mean prevalence
of low IQ i.e. IQ<70 from bacterial causes was approximately 5% is lower than a previous esti-
mate of 9.1% by Edmond et al. 2010,[4] however that study provided no details on how the
quality of IQ data in included studies was assessed and likely included studies considered ineli-
gible by our review. Previous systematic reviews have suggested that the prevalence of major
sequelae is highest after SP meningitis,[4] however we were unable to confirm this largely due
to lack of high quality SP studies. No previous systematic reviews have examined the impact of
viral meningitis on IQ.
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Fig 5. Forest plot of mean difference in Verbal and Performance IQ between meningitis survivors and
controls by organism. Panel A shows Verbal IQ and Panel B shows Performance IQ. Abbreviations: Haemophilus
influenzae b (Hib), Streptococcus pneumoniae (SP) Neisseria meningitides (NM), group B streptococcus (GBS);
weighted mean difference (WMD)
https://doi.org/10.1371/journal.pone.0175024.g005
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Strengths and limitations
We undertook an extensive systematic review using search terms similar to a previously pub-
lished systematic review[4] and undertook thorough hand-searching of reviewed articles. We
included only studies which used validated measures of intelligence or early childhood devel-
opment and which reported adequate data to allow assessment. Random effects meta-analyses
were undertaken to allow for significant heterogeneity seen in many meta-analyses.
These data are subject to a number of limitations. The great majority of studies were under-
powered. A number of studies, including those some of potentially high quality, were excluded
as they only reported findings for sub-groups of survivors. There were few population-based
studies, with the great majority being hospital series and thus open to recruitment bias. In
Table 2. Developmental delay (DD) by organism and developmental domain in CC and cohort studies.
N of
studies
CC studies: effect size (Cohen’s d) for DD compared
with controls (Instrument used)
Cohort studies: prevalence of DD in meningitis survivors
(Instrument used)
Bacterial all-
cause
3 Dodge 2001: d = 0.5 delay (VSMS) Singhi 2007: 34.5% (n = 20) with global developmental delay
(DDST)
Jiang 1990: DD in 17.4% (n = 8) (DDST)
Neonatal
bacterial
2 Doctor 2001: cognitive delay d = 0.6, motor delay d = 0.5
(BSID)
Klinger 2000: 10% (n = 10) moderate or severe DD, defined as
scores2 SD below mean (BSID)
SP 3 1. Goetghebuer 2000: 36% (n = 10) with cognitive delay and
76% (n = 16) with gross motor delay (DDST)
2. Jadavji 1986; 13.3% (n = 4) with DD defined as performance
2 months below chronological age (BSID)
3. Letson 1992: 10% (n = 1) with motor delay and 20% (n = 2)
with language delay (various standardised tests)
HIB 4 Wright 1971: no differences in cognitive development
(Bender-Gestalt & Frostig Developmental tests)
1. Goetghebuer 2000: 15% (n = 6) with cognitive delay; 19%
(n = 5) with gross motor delay (DDST).
2. Letson et al. (1992): 14% (n = 6) with motor delay; 33%
(n = 14) with language delay (various standardized tests)
3. Jadavji 1986: DD in 4% (n = 5) defined as2 months below
chronological age (BSID & VG).
NM 1 Jadavji 1986: Nil with DD defined as2 months below
chronological age (BSID & VG).
GBS 1 Wald 1986: visuo-motor integration delay d = 0.58 (various
standardized tests)
Viral 3 Bergman 1987: No differences in motor, language or
cognitive development (various standardized tests)
Chang 2007: Nil with DD (DDST).
Baker 1996: No delay in first 2 years post meningitis (BSID
& PPVT)
TB 0
Table shows findings for DD assessed using validated standardised instruments from CC studies and from other studies. Findings for case control studies
are shown as effect sizes expressed as Cohen’s delta (d) for the difference between cases and controls. Findings from other studies report proportions with
DD. Only significant (p<0.05) differences are shown.
Abbreviations
CA: Chronological age
DDST: Denver Developmental Screening Test
BSID: Bayley Scale of Infant Development
PPVT: Peabody Picture Vocabulary Test
VSMS: Vineland Social Maturity Scale
VG: Vineland-Griffiths test
LBW: low birth weight, <1.5kg
d: Cohen’s D
Abbreviations: Haemophilus influenzae b (Hib), streptococcus pneumoniae (SP) neisseria meningitides (NM), group B streptococcus (GBS)
https://doi.org/10.1371/journal.pone.0175024.t002
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some included studies, the sample that underwent cognitive testing was a subset of the overall
group of survivors, and this is likely to be a further source of bias. The direction of such biases
is unclear, as survivors with major cognitive deficits were potentially less likely to be recruited,
or conversely, parents of children more severely affected by meningitis may have been more
active in seeking recruitment to studies. Data on DD were particularly diverse, with studies
using different instruments and reporting across different domains, making findings difficult
to synthesize. Data were insufficient to summarize by developmental domain. Because of this
we believe that our systematic review only provides moderate evidence for the effects of men-
ingitis on IQ and development.
Conclusions
We found moderate evidence that bacterial meningitis is associated with significant and clinically
meaningful reductions in overall, verbal and performance IQ and with meaningful developmental
delay in survivors compared with healthy controls. We found no effects of viral meningitis on IQ
or developmental progress. We found data quality of studies to be limited. Further work is needed
to robustly evaluate the sequelae of differing forms of meningitis, particularly in low-income
countries. Survivors of bacterial should be routinely offered screening for cognitive deficits and
developmental delay in addition to hearing loss. These data will inform cost-effectiveness assess-
ments of future vaccines and planning of service provision for survivors.
Supporting information
S1 Checklist. PRISMA 2009 checklist.
(DOC)
S1 Table. Characteristics of reviewed studies.
(DOCX)
Author Contributions
Conceptualization: DC HEB RB RV.
Data curation: DC HR HEB FS TS RV.
Formal analysis: DC RV.
Funding acquisition: DC RV HEB RB.
Investigation: DC RV HEB HR RB.
Methodology: DC RV HEB RB.
Project administration: DC RV HEB HR RB.
Supervision: DC RV HEB RB.
Writing – original draft: DC RV HEB HR RB.
Writing – review & editing: DC RV HEB HR RB.
References
1. McIntyre PB, O’Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis
worldwide. Lancet. 2012; 380:1703–11 https://doi.org/10.1016/S0140-6736(12)61187-8 [published
Online. PMID: 23141619
Meningitis and IQ: A meta-analysis
PLOS ONE | https://doi.org/10.1371/journal.pone.0175024 August 24, 2017 13 / 14
2. Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-
specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of
Disease Study 2013. Lancet. 2015; 385:117–71 https://doi.org/10.1016/S0140-6736(14)61682-2 [pub-
lished Online. PMID: 25530442
3. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al. Years lived with disability (YLDs)
for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden
of Disease Study 2010. Lancet. 2012; 380:2163–96 https://doi.org/10.1016/S0140-6736(12)61729-2
[published Online. PMID: 23245607
4. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of dis-
abling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis.
2010; 10:317–28 https://doi.org/10.1016/S1473-3099(10)70048-7 [published Online First: 2010/04/27].
PMID: 20417414
5. Sadarangani M, Willis L, Kadambari S, et al. Childhood meningitis in the conjugate vaccine era: a pro-
spective cohort study. Arch Dis Child. 2015; 100:292–4 https://doi.org/10.1136/archdischild-2014-
306813 [published Online. PMID: 25256088
6. van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis.
Lancet. 2012; 380:1693–702 https://doi.org/10.1016/S0140-6736(12)61186-6 [published Online.
PMID: 23141618
7. Damsgaard J, Hjerrild S, Andersen H, Leutscher PD. Long-term neuropsychiatric consequences of
aseptic meningitis in adult patients. Infect Dis (Lond). 2015; 47:357–63 https://doi.org/10.3109/
23744235.2015.1018838 [published Online. PMID: 25738613
8. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moisi JC, Were F, Levine OS. Sequelae due to bacterial
meningitis among African children: a systematic literature review. BMC medicine. 2009; 7:47 https://doi.
org/10.1186/1741-7015-7-47 [published Online. PMID: 19751516
9. Wraw C, Deary IJ, Gale CR, Der G. Intelligence in youth and health at age 50. Intelligence. 2015;
53:23–32 https://doi.org/10.1016/j.intell.2015.08.001 [published Online. PMID: 26766880
10. Calvin CM, Deary IJ, Fenton C, Roberts BA, Der G, Leckenby N et al. Intelligence in youth and all-
cause-mortality: systematic review with meta-analysis. Int J Epidemiol. 2011; 40:626–44 https://doi.org/
10.1093/ije/dyq190 [published Online. PMID: 21037248
11. Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H et al. Outcomes of invasive menin-
gococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet
neurology. 2012; 11:774–83 https://doi.org/10.1016/S1474-4422(12)70180-1 [published Online First:
2012/08/07]. PMID: 22863608
12. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningits in children.: a meta-analysis. Pediatric
Infectious Disease. 1993; 12:389–94 Online.
13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-
analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analy-
ses. Lancet. 1999; 354:1896–900 Online. PMID: 10584742
14. Fass PS. The IQ: A cultural and historical framework. American Journal of Education. 1980; 88:431–58
Online.
Meningitis and IQ: A meta-analysis
PLOS ONE | https://doi.org/10.1371/journal.pone.0175024 August 24, 2017 14 / 14
